Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2017-03-15 | "Mr. Aronin is chairman and chief executive officer of Paragon Pharmaceuticals... and is chairman and chief executive officer of Marathon Pharmaceuticals..." |
| 2018-03-12 | "Mr. Aronin has experience as a chief executive officer leading several global biopharmaceutical companies. His skills include strategy and business development, finance and brand marketing." |
| 2019-03-25 | "Mr. Aronin has been chairman and chief executive officer of Paragon Pharmaceutical Capital, LLC..." |
| 2020-03-23 | "Mr. Aronin has been chairman and chief executive officer of Paragon Pharmaceutical Capital, LLC... and Paragon Biosciences, LLC..." |
| 2021-03-12 | "Mr. Aronin has been chairman and chief executive officer of Paragon Pharmaceutical Capital, LLC... and Paragon Biosciences, LLC... His skills include strategy and business development, finance and brand marketing." |
| 2022-03-25 | "Mr. Aronin is the founder, chairman and chief executive officer of Paragon Biosciences, a global life science innovator... Prior to Paragon, Mr. Aronin was CEO of several global biopharmaceutical companies..." |
| 2023-03-17 | “Founder, chairman and chief executive officer of Paragon Biosciences, LLC, an affiliated global life science innovation and investment firm” |
| 2024-03-15 | “Former Managing Partner, Washington, D.C. metropolitan area of KPMG LLP” and “Relevant Skills and Experience • Leading and managing a large accounting firm’s growth priorities...” |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-09